Pulmonary artery denervation takes another step in hypertension

Pulmonary artery denervation takes another step in hypertension

Pulmonary Artery Denervation (PADN) Combined with a Phosphodiesterase-5 Inhibitor Improved Exercise Capacity, Cardiac Function, and Some Clinical Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) in a Controlled Trial fictitious. The primary endpoint of change from baseline in 6-minute walking distance increased in both groups at 30 days, with a median change at 6 months …

Pulmonary artery denervation takes another step in hypertension Read More »